ArticlePLoS pathogens2014
Detecting differential transmissibilities that affect the size of self-limited outbreaks.
Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.
- Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review.Antimicrobial resistance and infection control · 2023Pooled it
- Temporal and age-structured analysis of Mpox spread in the 2022 Global outbreak: data-assimilation insights for epidemic control.Infectious diseases of poverty · 2025Article
- Epidemiological inference at the threshold of data availability: an influenza A(H1N2)v spillover event in the United Kingdom.Journal of the Royal Society, Interface · 2024Article
- Monkeypox in Latin America and the Caribbean: assessment of the first 100 days of the 2022 outbreak.Pathogens and global health · 2023Article
- Mathematical modeling of mpox: A scoping review.One health (Amsterdam, Netherlands) · 2023Article
- A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic.Epidemics · 2023Article
- Differences in the superspreading potentials of COVID-19 across contact settings.BMC infectious diseases · 2022Article
- Maintenance of Measles Elimination Status in the United States for 20 Years Despite Increasing Challenges.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022Article
- Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam.eLife · 2022Article
- Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility.PLoS computational biology · 2022Article
- Characterizing tuberculosis transmission dynamics in high-burden urban and rural settings.Scientific reports · 2022Article
- Analysis of Superspreading Potential from Transmission Clusters of COVID-19 in South Korea.International journal of environmental research and public health · 2021Article
- Challenges in evaluating risks and policy options around endemic establishment or elimination of novel pathogens.Epidemics · 2021Article
- OutbreakFlow: Model-based Bayesian inference of disease outbreak dynamics with invertible neural networks and its application to the COVID-19 pandemics in Germany.PLoS computational biology · 2021Article
- Mitigating outbreaks in congregate settings by decreasing the size of the susceptible population.medRxiv : the preprint server for health sciences · 2021Article
- Transmission Dynamics, Heterogeneity and Controllability of SARS-CoV-2: A Rural-Urban Comparison.International journal of environmental research and public health · 2021Article
- Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020.BMC medicine · 2020Article
- Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020.medRxiv : the preprint server for health sciences · 2020Article
- Controlling emerging zoonoses at the animal-human interface.One health outlook · 2020Article
- Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China.Wellcome open research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
Abstract
Our ability to respond appropriately to infectious diseases is enhanced by identifying differences in the potential for transmitting infection between individuals. Here, we identify epidemiological traits of self-limited infections (i.e. infections with an effective reproduction number satisfying [0 < R eff < 1) that correlate with transmissibility. Our analysis is based on a branching process model that permits statistical comparison of both the strength and heterogeneity of transmission for two distinct types of cases. Our approach provides insight into a variety of scenarios, including the transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in the Arabian peninsula, measles in North America, pre-eradication smallpox in Europe, and human monkeypox in the Democratic Republic of the Congo. When applied to chain size data for MERS-CoV transmission before 2014, our method indicates that despite an apparent trend towards improved control, there is not enough statistical evidence to indicate that R eff has declined with time. Meanwhile, chain size data for measles in the United States and Canada reveal statistically significant geographic variation in R eff, suggesting that the timing and coverage of national vaccination programs, as well as contact tracing procedures, may shape the size distribution of observed infection clusters. Infection source data for smallpox suggests that primary cases transmitted more than secondary cases, and provides a quantitative assessment of the effectiveness of control interventions. Human monkeypox, on the other hand, does not show evidence of differential transmission between animals in contact with humans, primary cases, or secondary cases, which assuages the concern that social mixing can amplify transmission by secondary cases. Lastly, we evaluate surveillance requirements for detecting a change in the human-to-human transmission of monkeypox since the cessation of cross-protective smallpox vaccination. Our studies lay the foundation for future investigations regarding how infection source, vaccination status or other putative transmissibility traits may affect self-limited transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.